Therapeutics Acquisition Corp. (RACA)
$10.2743
+0.24 (+2.44%)
Rating:
Recommendation:
-
| Symbol | RACA |
|---|---|
| Price | $10.2743 |
| Beta | 0.000 |
| Volume Avg. | 0.14M |
| Market Cap | 1.085B |
| Shares () | - |
| 52 Week Range | 10-10.33 |
| 1y Target Est | - |
| DCF Unlevered | RACA DCF -> | |
|---|---|---|
| DCF Levered | RACA LDCF -> | |
| ROE | - | |
| ROA | - | |
| Operating Margin | - | |
| Debt / Equity | - | |
| P/E | - | |
| P/B | - |
Latest RACA news
About
Download (Excel)Dr. Peter Kolchinsky Ph.D.
Financial Services
Shell Companies
Nasdaq Capital Market
Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.